Baricitinib Shortage Update: What Patients Need to Know in 2026

Updated:

February 27, 2026

Author:

Peter Daggett

Summarize this blog with AI:

Is Baricitinib (Olumiant) in shortage in 2026? Get the latest update on availability, pricing, and what you can do if you can't find your prescription.

Baricitinib in 2026: Is There Still a Shortage?

If you rely on Baricitinib (Olumiant) for rheumatoid arthritis, alopecia areata, or another condition, you want to know one thing: can I get my medication?

Baricitinib experienced some supply disruptions in the past, particularly during 2020-2021 when demand spiked due to its emergency use for COVID-19 treatment. But what's the situation now? In this article, we'll give you the latest update on Baricitinib availability and what to do if you're having trouble finding it.

Is Baricitinib Still in Shortage?

As of February 2026, Baricitinib is not listed on the FDA drug shortage database. This means the FDA considers the overall market supply adequate to meet demand.

However, "not in shortage" doesn't mean "easy to find." Baricitinib is a specialty medication made by a single manufacturer (Eli Lilly), and it's not stocked at most retail pharmacies. So even though supply exists, accessing it can still be challenging for individual patients.

Why Can Baricitinib Still Be Hard to Find?

Even without an official shortage, patients report difficulty getting Baricitinib for several reasons:

  • Specialty pharmacy requirements — most insurance plans require you to use a designated specialty pharmacy, not your local CVS or Walgreens
  • Prior authorization delays — insurance companies require paperwork proving medical necessity, which can take days to weeks
  • Step therapy mandates — you may need to try and fail other medications (like Methotrexate or a TNF inhibitor) before your insurer will approve Baricitinib
  • No generic available — without generic competition, Eli Lilly is the sole source of supply in the US

For a deeper explanation, read our article on why Baricitinib is so hard to find.

How Much Does Baricitinib Cost in 2026?

Baricitinib remains a high-cost medication. Here's what you can expect to pay:

  • Without insurance: $2,500 to $3,000 per month for a 30-day supply of Olumiant tablets
  • With commercial insurance: Copays vary widely, but specialty tier medications often have copays of $100 to $500+ per month before any savings programs
  • With the Olumiant Savings Card: As low as $5 per month for eligible commercially insured patients
  • With patient assistance: $0 through the Lilly Cares Foundation for qualifying uninsured or underinsured patients

For detailed information on reducing your costs, see our guide to saving money on Baricitinib.

Are There New Options for Patients in 2026?

The JAK inhibitor landscape continues to evolve. While no generic Baricitinib is available yet, patients now have more treatment options than ever:

  • Ritlecitinib (Litfulo) — approved in 2023 for severe alopecia areata, giving patients another option beyond Baricitinib for hair loss
  • Upadacitinib (Rinvoq) — has expanded its approved indications and may be an option for RA patients who can't access Baricitinib
  • Biosimilar TNF inhibitors — while not JAK inhibitors, biosimilar versions of Adalimumab (Humira) are now available at lower cost and may be suitable for some RA patients

Talk to your doctor about whether any of these options might work for you. Our alternatives guide covers the details.

How to Find Baricitinib in Stock

If you need Baricitinib right now, here are the most effective steps:

  1. Check Medfinder — search for real-time pharmacy availability in your area
  2. Contact your specialty pharmacy — if you don't know which one to use, call your insurance company's pharmacy benefits line
  3. Ask your doctor's office for help — many rheumatology and dermatology practices have staff who specialize in navigating specialty medication access
  4. Call Eli Lilly — the manufacturer can help connect you with available supply at 1-800-545-5979

For more tips, read our complete guide on how to find Baricitinib in stock near you.

Final Thoughts

The good news is that Baricitinib is not in shortage in 2026. The bad news is that specialty medication access in the US healthcare system remains complicated. Between insurance requirements, specialty pharmacy channels, and high costs, getting Baricitinib can feel like navigating a maze.

But with the right information and tools, you can get your medication. Start with Medfinder to check availability, explore savings programs, and work with your healthcare team to stay on track with your treatment.

Is there a Baricitinib shortage in 2026?

No. As of February 2026, Baricitinib (Olumiant) is not listed on the FDA drug shortage database. Supply from the manufacturer, Eli Lilly, appears stable. However, individual patients may still face access challenges due to specialty pharmacy requirements and insurance barriers.

When was the last Baricitinib shortage?

Baricitinib experienced intermittent supply disruptions during 2020-2021, primarily because of increased demand when it received emergency use authorization for COVID-19 treatment. Supply has since stabilized.

Will a generic version of Baricitinib be available soon?

As of 2026, no generic version of Baricitinib has been approved in the United States. Patent protections for Olumiant extend through the mid-to-late 2020s. When a generic becomes available, it could significantly reduce the cost of this medication.

What should I do if I can't find Baricitinib at my pharmacy?

First, check real-time availability on Medfinder (medfinder.com). Then contact your insurance company to find your designated specialty pharmacy. If needed, ask your doctor about alternative JAK inhibitors like Tofacitinib (Xeljanz) or Upadacitinib (Rinvoq).

Why waste time calling, coordinating, and hunting?

You focus on staying healthy. We'll handle the rest.

Try Medfinder Concierge Free

Medfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.

25,000+ have already found their meds with Medfinder.

Start your search today.
99% success rate
Fast-turnaround time
Never call another pharmacy